Geelong 28th October丨 Midea Medical (301033.SZ) announced its third quarter report for 2024, with the company achieving revenue of 0.191 billion yuan in the first three quarters, a year-on-year increase of 30.98%; net income attributable to shareholders of listed companies was 52.803 million yuan, a year-on-year increase of 107.68%; net income attributable to shareholders of listed companies after deducting non-recurring gains and losses was 46.0877 million yuan, a year-on-year increase of 108.37%; basic earnings per share was 0.80 yuan. The growth in revenue was mainly due to the company orderly carrying out work around the operational goals set at the beginning of the year, with an increase in product sales and revenue as the market marketing efforts intensified.

In the third quarter, the company achieved revenue of 68.8939 million yuan, a year-on-year increase of 14.70%; net income attributable to shareholders of listed companies was 20.4123 million yuan, a year-on-year increase of 50.83%; net income attributable to shareholders of listed companies after deducting non-recurring gains and losses was 18.4115 million yuan, a year-on-year increase of 44.96%; basic earnings per share was 0.31 yuan.